Echinacea purpurea is ineffective for upper respiratory tract infections in children - 24/08/11
Abstract |
Question |
How safe and effective is Echinacea purpurea at reducing the duration and severity of upper respiratory tract infections in children?
Study design |
Multicentre randomised controlled trial.
Main results |
There was no significant difference in duration or severity of symptoms with Echinacea purpurea compared with placebo in children with upper respiratory tract infection (median duration of symptoms (95% CI): 9 days (8 to 10 days) with Echinacea vs. 9 days (8 to 10 days) with placebo; P=0.89; median severity of symptoms (95% CI): 33 (29 to 40) with Echinacea vs. 33 (30 to 38) with placebo; P=0.69). Rash occurred in significantly more children receiving Echinacea compared with placebo (reports of rash: 24 with Echinacea v 10 with placebo; P=0.008).
Authors’ conclusions |
Echinacea purpurea is ineffective for treating upper respiratory tract infections in children aged 2 to 11 years.
Le texte complet de cet article est disponible en PDF.Keywords : Upper respiratory tract infections, Echinacea purpurea, Children, Randomised controlled trial
Plan
Abstracted from: Taylor JA, Weber W, Standish L et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children. A randomized controlled trial. JAMA 2003; 290: 2824–2830. |
Vol 8 - N° 3
P. 165-167 - juin 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?